Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
IAC Express
|
2013 Issues
|
Issue 1057
IAC Express: Weekly immunization news and information
Issue 1057: May 28, 2013

TOP STORIES

IAC HANDOUTS

FEATURED RESOURCES

JOURNAL ARTICLES AND NEWSLETTERS



TOP STORIES

New! May 2013 issue of Vaccinate Adults now online
The May 2013 issue of Vaccinate Adults has just been placed online. Download May 2013 issue of Vaccinate Adults!

Note: Vaccinate Adults is an abbreviated version of Needle Tips with the pediatric content removed.

This issue of Vaccinate Adults gives healthcare professionals up-to-date information on meningococcal vaccination and features the newly published 2013 U.S. immunization schedule for adults. It also includes a new series of eight handouts for adults and teens about vaccine-preventable diseases and the importance of getting vaccinated. As always, the issue features the "Ask the Experts" column from CDC medical epidemiologist Andrew T. Kroger, MD, MPH; nurse educator Donna L. Weaver, RN, MN; and medical officer Iyabode Akinsanya-Beysolow, MD, MPH.

Back to top


Reminder: May 2013 issue of Needle Tips online
The May 2013 issue of Needle Tips is online.
Download the May 2013 issue of Needle Tips

Back to top


IAC Spotlight! Seven more healthcare organizations join IAC's Honor Roll for Patient Safety
IAC urges qualifying healthcare organizations to apply for its Honor Roll for Patient Safety. The honor roll recognizes hospitals, medical practices, professional organizations, and government entities that have taken a stand for patient safety by implementing mandatory influenza vaccination policies for healthcare personnel. More than 250 organizations are now enrolled.

Since April 30, when IAC Express last reported on the Honor Roll for Patient Safety, the following seven organizations have been enrolled.

Healthcare organizations and health agencies: DaVita HealthCare Partners, Torrance, CA; Via Christi Hospital Pittsburg, Pittsburg, KS; Baltimore Medical System, Baltimore, MD; Upper Missouri District Health Unit, Williston, ND; Elliot Healthcare System, Manchester, NH; Summa Health System, Akron, OH; and INTEGRIS Grove Hospital, Grove, OK.

Related Links

  • Listing of all honorees by state
  • Position statements from professional societies and leading healthcare organizations in support of mandatory influenza vaccination
  • Honor roll web section, which includes access to the application form (see the gold trophy cup in right column, and click on the words "Apply for the Honor Roll")
Back to top


IAC HANDOUTS

IAC revises its two most popular staff education materials, "Summary of Recommendations for Child/Teen Immunization" and "Summary of Recommendations for Adult Immunization"
IAC recently updated its two most popular educational resources for healthcare professionals. Both the Summary of Recommendations for Child/Teen Immunization and the Summary of Recommendations for Adult Immunization were revised based on updated ACIP recommendations and on decisions made and votes taken at the February 2013 ACIP meeting.

IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely.

Back to top


IAC updates its staff education materials "Current Dates of Vaccine Information Statements" and "It's Federal Law! You must give your patients current Vaccine Information Statements (VISs)"
IAC recently revised Current Dates of Vaccine Information Statements (VISs) and It's Federal Law! You must give your patients current Vaccine Information Statements (VISs). Both now include the issue date of the most recent version of the Gardasil HPV VIS, which CDC posted on May 17. For information on the Gardasil HPV VIS, see the IAC Express article titled CDC releases updated HPV (Gardasil) VIS, which was published on May 21.

Related Links
Back to top


FEATURED RESOURCES

Order IAC's popular full-size laminated versions of the 2013 U.S. immunization schedules today!
IAC's laminated versions of the 2013 U.S. child/teen and adult immunization schedules are covered with a tough, washable coating that lets them stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Each has six pages (i.e., three double-sided pages) and is folded to measure 8.5" by 11".

IAC's Laminated Child and Teen Immunization SchedulesIAC's Laminated Adult Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top


JOURNAL ARTICLES AND NEWSLETTERS

CDC publishes report on value of pharmacy-based influenza surveillance
CDC published Value of Pharmacy-Based Influenza Surveillance—Ontario, Canada, 2009 in the May 24 issue of MMWR (pages 401–404). The first two paragraphs of the article are reprinted below.

As part of ongoing efforts by the Public Health Agency of Canada (PHAC) to enhance disease surveillance, a retrospective epidemiologic study was undertaken to investigate the usefulness for influenza surveillance of data on changes in the volume of prescriptions for antiviral medications. The weekly numbers of dispensed prescriptions for the antiviral medications oseltamivir and zanamivir, as a proportion of all dispensed prescriptions, were compared with the numbers of confirmed laboratory reports of influenza A(H1N1) at the local health authority level in Ontario, Canada, during the second wave of the outbreak of pandemic influenza A(H1N1) in 2009. Qualitative and quantitative analyses demonstrated that antiviral prescription dispensing dates were a reasonable proxy for influenza A(H1N1) onset dates at the local health authority level. This report describes the results of those analyses, which indicated that (1) antiviral prescription proportions increased in advance of laboratory reports of influenza and (2) antiviral dispensing data can be available in near real-time. These findings suggest that pharmacy prescription data can provide timely intelligence to help characterize local influenza activity.

The value of influenza surveillance depends in part on the timeliness of the generated information. Traditional methods of influenza surveillance, including FluWatch (Canada’s national surveillance system), rely on the collection and aggregation of laboratory results and clinical observations from physicians and public health authorities. Typical for infectious diseases, it can take several days to weeks from symptom onset to data being collected, aggregated, and analyzed. Pharmacy-based surveillance uses near real-time dispensing data of pharmaceuticals (prescription and over-the-counter drugs) as a proxy for illness in the population. The potential for pharmacy-based surveillance to detect changes in community illness levels earlier than traditional laboratory-based surveillance methods is premised on the fact that the public will routinely seek over-the-counter medications to relieve or alleviate common symptoms of illness, and physicians often will prescribe medications before receiving laboratory confirmation. Retrospective disease outbreak studies have demonstrated increases in pharmaceutical sales before the recognition of increased illness frequency using traditional public health surveillance methods.


Back to top


CDC publishes report on building laboratory capacity to support the Global Rotavirus Surveillance Network
CDC published Building Laboratory Capacity to Support the Global Rotavirus Surveillance Network in the May 24 issue of MMWR (pages 409–412). The first two paragraphs of the article's Comment section are reprinted below.

The Global Rotavirus Laboratory Network (GRLN) is an integral part of the Global Rotavirus Surveillance Network that provides timely rotavirus disease burden data, which can help guide decisions regarding rotavirus vaccine introduction into national immunization programs. These data also can provide a baseline for assessing the impact of rotavirus vaccines on severe rotavirus disease resulting in hospitalization and on strain prevalence.

Substantial progress has been made in expanding the reach of the GRLN, developing standardized data collection procedures, and implementing quality assurance procedures to improve data collection. Lessons learned and applied from the other WHO-coordinated laboratory networks have resulted in a system of national, regional, and global laboratories proficient in rotavirus diagnosis and genotyping. Efforts are underway to optimize critical laboratory procedures used at the global and regional reference laboratories to facilitate interlaboratory data comparability and improve genotyping data quality.


Back to top



About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.
If you have trouble receiving or displaying IAC Express messages, visit our online help section.
IAC Express is supported in part by Grant No. U38IP000589 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: CSL Biotherapies; GlaxoSmithKline; MedImmune, Inc.; Merck Sharp & Dohme Corp.; Novartis Vaccines; Ortho Clinical Diagnostics, Inc.; Pfizer, Inc.; and sanofi pasteur.
IAC Express Disclaimer
ISSN: 1526-1786

Our mailing address is
Immunization Action Coalition
1573 Selby Ave, Ste 234
St. Paul, MN 55104

Copyright (C) 2013 Immunization Action Coalition
All rights reserved.

Subscribe Today: IAC Express, Needle Tips, and Vaccinate Adults: the up-to-date immunization information you need
IAC Express
IAC Express Home
2014 Issues
2013 Issues
2012 Issues
2011 Issues
2010 - 1997 Issues
Praise for IAC Express
Help
Disclaimer
Video of the Week
Video: Value of Vaccination
Value of Vaccination: Watch this short animated video from the GAVI Alliance about the value of vaccination. Vaccines are one of the most successful and cost-effective health investments in history.
Learn more
Visit the VOTW archive
Issue Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Publication Staff
Editor: Deborah L. Wexler, MD
Managing Editor: Dale Thompson, MA
Associate Editor: Teresa Anderson, DDS, MPH
Editorial Assistant: Janelle Tangonan Anderson
Additional Information
News & Information
Media coverage about vaccines and vaccine-preventable diseases
Calendar of Events
Conferences and meetings on immunization
Shop IAC
Record cards, laminated schedules and more
 
This page was reviewed on May 28, 2013
 
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.